Prenetics announces formation of scientific advisory board

Prenetics Global (PRE) announces the formation of a new Prenetics Scientific Advisory Board to provide strategic input based on their scientific knowledge and clinical expertise to help guide the further development of Prenetics’ diagnostic cancer genomics platform. Prenetics’ SAB appointees include: Prof. Mok will lead the SAB and currently serves as Chairman of the Department of Clinical Oncology of Chinese University of Hong Kong, is a non-executive director of AstraZeneca (AZN), and an independent director of HUTCHMED Limited. Prof. Pasi Janne is a translational thoracic medical oncologist at the Dana Farber Cancer Institute and Professor of Medicine at Harvard Medical School. Prof. Yang has been a professor in the department of internal medicine at the College of Medicine for 27 years. Dr. Hua Chien Chen is the Co-founder and the Chief Scientific Officer of ACT Genomics. Dr. Frank Ong, MD. Chief Medical Officer for Prenetics and Interim CEO for ACT Genomics. Dr. Lawrence Tzang is the Co-Founder of Prenetics and has served as its Chief Scientific Officer and director since its founding in 2014.